Blood Tests Can Predict the Risk of Liver Cirrhosis
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease.
Read More
Search Results for: obesity
ProSciento and Nordic Bioscience Partner to Develop Translational Biomarkers for NASH
The partnership will utilize ProSciento’s NASH Pass patient registry and Nordic Bioscience’s biomarker technology to identify and validate translational biomarkers to improve the diagnosis, prognosis, and development of therapeutics for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
Read MoreStudy Uncovers Increasing Global Rates of Liver Cancer
The researchers examined 1990–2017 data from the Global Burden of Disease Study pertaining to 195 countries and territories.
Read More
High Androgen Levels during Pregnancy Increase the Risk of PCOS for Several Generations
Daughters of women with polycystic ovarian syndrome are five times more likely to be diagnosed with the syndrome as adults, and the generational transmission is driven by high androgen levels during pregnancy.
Read More
Siemens Healthineers Launches Testing Service for Chronic Liver Disease
The ELF test allows for identification of chronic liver disease in patients, including nonalcoholic fatty liver disease.
Read More